Rob C.M. van Kruijsdijk

Cancer Risk in Patients with Manifest Vascular Disease: Effects of Smoking, Obesity, and Metabolic Syndrome

Rob C.M. van Kruijsdijk, Yolanda van der Graaf, Petra H.M. Peeters et al. · Cancer Epidemiology Biomarkers & Prevention · 2013 · 72 citations

Medicine, Oncology, Cancer Epidemiology +13

How to translate clinical trial results into gain in healthy life expectancy for individual patients

Jannick A N Dorresteijn, Lotte Kaasenbrood, Nancy R. Cook et al. · BMJ · 2016 · 62 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women

Rob C.M. van Kruijsdijk, Frank L.J. Visseren, Paul M. Ridker et al. · Heart · 2014 · 51 citations · Full text

Medicine, Pharmacology, Preventive Medicine +13

Sepsis-Related Myocardial Calcification

Rob C.M. van Kruijsdijk, Joris van der Heijden, Ruben Uijlings et al. · Circulation Heart Failure · 2011 · 34 citations · Full text

Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease

W Bakker, Hiddo J.L. Heerspink, Stefan P. Berger et al. · Nephrology Dialysis Transplantation · 2025 · 19 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13